Florentino Hernando-Trancho

6PUBLICATIONS
57CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersPhysiotherapyHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 15, 2026
Minimal Residual Disease Enhances Prognostic Stratification beyond Pathologic Response in Resectable Non-Small Cell Lung Cancer.

Mariano Provencio, Roberto Serna-Blasco, Ernest Nadal

|Jun 13, 2025
Oropharyngeal and Oral Cancer in Lung Cancer Patients: Do They Present a Worse Prognosis than Isolated Lung Cancer Patients?

Farzin Falahat Noushzady, Sonia Herrero Álvarez, Joaquín Calatayud Gastardi

|Jan 25, 2025
Fecal Microbiota Strongly Correlates with Tissue Microbiota Composition in Colorectal Cancer but Not in Non-Small Cell Lung Cancer.

Juan Vicente-Valor, Sofía Tesolato, Mateo Paz-Cabezas

|Jan 27, 2022
Surgical resection of Masaoka stage III thymic epithelial tumours with great vessels involvement: a retrospective multicentric analysis from the European Society of Thoracic Surgeons thymic database.

Paolo Mendogni, Alper Toker, Bernhard Moser

|Aug 02, 2021
Targeted therapy moves to earlier stages of non-small-cell lung cancer: emerging evidence, controversies and future challenges.

Xabier Mielgo-Rubio, Margarita Martín, Jordi Remon

Pageof 1